Breaking News

CEPI Establishes Global Lab Network to Assess COVID-19 Vax Candidates

Will use the same testing reagents to assess and compare the immunological responses generated by COVID-19 vaccine candidates.

By: Contract Pharma

Contract Pharma Staff

The Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with five clinical sample testing labs to create a centralized global network to assess and compare the immunological responses generated by COVID-19 vaccine candidates. The labs initially selected for this vaccine-assessment network are: Nexelis (Canada) and Public Health England (PHE, UK), VisMederi Srl (Italy), Viroclinics-DDL (The Netherlands), icddr,b (formerly International Centre for Diarrhoeal Disease Research, ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters